Pfizer shares fall as 2024 revenue and profit forecast disappoints

[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products.  Pfizer also…

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie…

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to…

The FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other massive pharma deals

[ad_1] Robert Galbraith | Reuters The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement –  a…

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

[ad_1] The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on Friday said it…

Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more

[ad_1] People are seen inside the First Republic Bank branch in Midtown Manhattan in New York City, New York, U.S., March 13, 2023. REUTERS/Mike Segar Mike Segar | Reuters Check…